Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/Glycopyrronium Bromide/Formoterol in PRISm
NCT07595796Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2026
- Primary completion
- Feb 2028
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of budesonide, glycopyrronium and formoterol, sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Trough forced expiratory volume in the first second at Week 12. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
budesonideglycopyrroniumformoterol
Beyond the preview
Go deeper on NCT07595796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07595796.